PDF Cover

Mandibular Advancement Devices Market

The market for Mandibular Advancement Devices was estimated at $627 million in 2024; it is anticipated to increase to $910 million by 2030, with projections indicating growth to around $1.24 billion by 2035.

Report ID:DS1801145
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Mandibular Advancement Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Mandibular Advancement Devices Market Outlook

Revenue, 2024

$627M

Forecast, 2034

$1.17B

CAGR, 2025 - 2034

6.4%

The Mandibular Advancement Devices (MAD) industry revenue is expected to be around $667.6 million in 2025 and expected to showcase growth with 6.4% CAGR between 2025 and 2034. The forecast indicates Mandibular Advancement Devices (MAD) will become more important for healthcare because patients and medical organizations now focus on treating sleep-disordered breathing through non-surgical methods. The market demand increases because people develop obesity-related obstructive sleep apnea more frequently while medical professionals understand better how snoring causes heart problems and patients prefer oral appliances for sleep apnea treatment because they offer a simple alternative to CPAP devices. The market uses Mandibular Advancement Devices to treat Obstructive Sleep Apnea and Snoring in 77.3% of cases while Custom MAD product type leads the market with $327.52 million in sales during 2024 because customers prefer custom-fitted devices which provide better comfort and improved treatment success. The design of Mandibular Advancement Devices includes intraoral adjustable mandibular splints which move the lower jaw forward to support the upper airway while using small designs and adjustable components and modern lightweight materials which are friendly to the body. The main purpose of these devices exists to treat obstructive sleep apnea and stop people from snoring but doctors now use them to treat dental sleep disorders at the beginning stages of the disease for patients who cannot use CPAP therapy. The Mandibular Advancement Devices market undergoes transformation because digital dentistry workflows now use CAD/CAM design and 3D-printed oral devices which provide exact device customization and quick manufacturing and large-scale manufacturing capabilities. The market for these new oral appliances continues to grow because of three recent developments which include home sleep testing integration and sleep clinic-dental practice partnerships and evidence-based treatment protocols.

Mandibular Advancement Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Mandibular Advancement Devices Market Outlook

Market Key Insights

  • The Mandibular Advancement Devices market is projected to grow from $627.4 million in 2024 to $1.17 billion in 2034. This represents a CAGR of 6.4%, reflecting rising demand across Sleep Apnea Treatment, Snoring Prevention, and Teeth Grinding (Bruxism) Management.

  • The market operates as an oligopoly because it contains seven major companies which ResMed Inc and SomnoMed lead in market share.

  • The Mandibular Advancement Devices market shows its highest demand through U.S. and Germany as these countries will experience market expansion at 4.2% to 6.1% CAGR from 2024 to 2030.

  • The research predicts Brazil, India and South Africa will experience the most significant market expansion at rates between 7.4% and 8.8% CAGR.

  • The current 6.4% low growth rate has industry players working to implement Technological Innovations as future transitions but they also plan to dedicate $30 million to investments until 2030.

  • The Mandibular Advancement Devices market will experience $539 million growth during 2024-2034 while manufacturers focus on developing Obstructive Sleep Apnea & TMJ Syndrome Application solutions which will dominate market expansion.

  • The worldwide spread of sleep apnea has led to an 86% market expansion for Mandibular Advancement Devices which will continue through 2034.

mandibular advancement devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Mandibular Advancement Devices - Country Share Analysis

Opportunities in the Mandibular Advancement Devices

European telemedicine sleep care platforms have also started working with dental clinics to create a system which enables distant medical evaluations and MAD delivery. The combination of digital dentistry systems which use intraoral scanning and CAD/CAM manufacturing enables fast production of customized MAD devices for treating obstructive sleep apnea. The worldwide custom MAD revenue will expand from 327.52 million in 2024 to 486.03 million during 2030 with a 6.8% annual growth rate which positions Europe as a leading market for oral appliance therapy reimbursement.

Growth Opportunities in North America and Europe

The main clinical application of Mandibular Advancement Devices in North America exists for treating Obstructive Sleep Apnea while snoring and TMJ syndrome have become increasingly important secondary uses because more healthcare providers now understand sleep apnea treatment options through dental and primary care networks. The main business opportunities focus on high-end Mandibular Advancement Devices which offer custom fit solutions as comfortable CPAP alternatives through digital dentistry processes and chairside titration and telemonitoring systems to gain better acceptance from dental sleep medicine practices and integrated sleep centers. The market competition between sleep-therapy brands and dental labs and DTC snoring devices has become more competitive which drives manufacturers to create distinct products through their ability to show clinical results and their work with insurance providers and their connection to home sleep testing systems. The market shows three main factors which drive customer demand because people with obesity develop sleep disorders that affect their breathing and employers support health programs and medical providers seek affordable solutions to treat TMJ disorders and OSA which leads to positive conditions for selling bundled products and extended service agreements.
The European market shows the greatest interest in Mandibular Advancement Devices which treat Obstructive Sleep Apnea while snoring devices and TMJ syndrome solutions demonstrate significant market potential in areas with established private-pay dental systems and customers who spend money on life quality enhancements. The company should create Mandibular Advancement Devices which match different regulatory requirements and clinical standards to serve public healthcare systems with evidence-backed sleep apnea treatments and private clinics with stylish devices that need multilingual educational materials for patients and doctors. The market contains three types of competitors which include regional dental labs and niche med-tech manufacturers and localized CPAP alternatives that drive competitors to compete through innovative biomechanical design and durable products and extensive distribution networks instead of using price as their main competitive factor. The market expansion results from three main factors which include aging populations and enhanced occupational health requirements and rising ENT and dental specialist patient referrals that create opportunities to position advanced snoring devices and TMJ disorder therapies in sleep and craniofacial pain centers that treat multiple conditions.

Market Dynamics and Supply Chain

01

Driver: Increasing Global Prevalence of Sleep Apnea, and Growing Awareness and Favourable Medical Insurance Policies

The prevalence of sleep apnea is also a growing concern with a focus on Obstructive Sleep Apnea. According to the World Health Organizations estimate of 100 million individuals affected by OSA highlights the urgent need for effective treatment options. With mandibular advancement devices standing out as a popular choice among patients due to their non invasive nature and ability to offer immediate relief from symptoms; thus driving an increase in the demand for MADs, within the market. Increasing public awareness about sleep disorders, including obstructive sleep apnea, is also fueling demand for mandibular advancement devices. Online platforms and health campaigns have also educated patients on the benefits of proper treatment. Simultaneously, health insurance providers are also expanding coverage for sleep disorder therapies, making MAD devices more accessible and affordable. This combination of awareness and supportive insurance policies is also driving market growth and adoption.
Continuous exploration and advancements in advancement devices play a crucial role as the second key factor here. Research and development efforts are also paving the way for the development of tailored devices that prioritize comfort for users. Furthermore the utilization of technology to enhance precise fitting and monitoring is also contributing to a surge in demand for these modernized mandibular devices due, to their improved success rates.
02

Restraint: Regulatory Landscape

In the realm of tools like mandibular advancement devices there are strict rules and regulations that companies must follow, set by health organizations and government bodies. Getting the light, for these products is a lengthy procedure that could hinder the introduction of new items and business growth. Adhering to safety and quality standards adds another layer of complexity often dissuading businesses from joining the industry.
03

Opportunity: Rising demand for noninvasive sleep apnea treatment among middle‑aged professionals in the United States and Expansion of dental sleep medicine clinics offering Mandibular Advancement Devices across rapidly urbanizing Asian megacities

Middle-aged working Americans in the United States now understand obstructive sleep apnea better which leads them to choose Mandibular Advancement Devices for their snoring problems. The healthcare system now provides payment for oral appliance therapy because it proves to be an affordable treatment option for patients who cannot use CPAP. The market shows preference for custom MAD and semi‑custom MAD designs because custom MAD revenues will expand from 327.52 million in 2024 to 486.03 million by 2030. The demand for dentist-supervised Mandibular Advancement Devices will increase because of corporate wellness programs which operate in all major urban areas.
The fast-paced urban growth of Asian megacities allows dental sleep medicine clinics to treat sleep-disordered breathing through Mandibular Advancement Devices because doctors fail to properly identify this condition. The middle class demonstrates increasing ability to spend money on sleep apnea treatment while showing interest in using chairside‑fitted bite MAD and semi‑custom MAD options for their treatment. The worldwide Bite MAD revenue will increase from 198.90 million in 2024 to 277.38 million during the 2030 period while semi-custom MAD will generate 146.95 million in revenue to establish Asia-based clinic networks as the leading expansion pathway.
04

Challenge: High Costs

Even though MAD work well in treating conditions like snoring or sleep apnea but these devices can be quite expensive to get on hands. These steep prices might put a damper on the market growth Especially in countries where people dont have cash to spare and healthcare isnt all that fancy either!. Insurance coverage for these gizmos can be all, over the place depending on the country and which brand is the preference! Putting it all together – these things make it kinda hard for people to snag one of these devices when they need em the most.

Supply Chain Landscape

1

Custom Dental Devices

Glidewell LaboratoriesSomnoMed Ltd
2

Mandibular Advancement Devices

ResMed IncAirway Management IncSomnoMed Ltd
3

Oral Appliance Therapy

MPowRx Health and Wellness Products IncAirway Management Inc
4

Sleep Apnea Treatment

sleep clinicsdental sleep medicine practiceshomecare settings
Mandibular Advancement Devices - Supply Chain

Use Cases of Mandibular Advancement Devices in Sleep Apnea Treatment & Teeth Grinding (Bruxism) Management

Sleep Apnea Treatment : In the realm of addressing obstructive sleep apnea issues little devices known as mandibular advancement devices hold value and importance. Among the MAD variations in the market the adjustable ones stand out as a popular choice largely due to their enhanced effectiveness and ability to be customized as per the individual patient needs. These devices operate by reposition the mandible forward during sleep resultig in an expanded airway space at the portion of the throat. This mechanism helps in averting airway collapse while an individuals asleep. Noteworthy players, in this field include ResMed and SomnoMed who are well regarded for their development of innovative and user friendly device solutions.
Snoring Prevention : Anti snoring devices have proven to be quite effective in minimizing or stopping snoring Prefabricated ASDS are commonly utilized for this purpose due to their easy availability and affordability These devices work by preventing the tongue from moving backward excessively thus decreasing the chance of airway blockage that leads to snoring Well known brands such as SnoreRx and Zyppah are recognized for offering user friendly and beneficial ASD options making them popular choices, in the market.
Teeth Grinding (Bruxism) Management : Many individuals rely on mandibular advancement devices to manage bruxism, using custom-fitted night guards made from durable materials that protect teeth from grinding and reduce jaw discomfort. Leading companies such as SleepRight and SmartGuard provide high-quality, long-lasting MAD devices designed specifically for bruxism patients. These devices not only prevent dental damage but also improve sleep quality, making them an essential solution in oral care and sleep disorder management.

Recent Developments

The market for advancement devices has experienced notable progress in recent times with a focus on enhancing comfort and effectiveness in addressing snoring and sleep apnea issues for users. An increasing inclination towards personalized devices is evident in market trends due to their tailored fit and enhanced comfort level for users specific needs. This shift, in consumer preference is anticipated to influence the evolution of the industry landscape.

December 2024 : ResMed introduced the AirFit N30I device designed to address snoring and obstructive sleep apnea in individuals. It is tailored for those seeking solutions to improve their sleep quality.
October 2024 : SomnoMed unveiled an enhanced edition of SomnoDen that focuses on enhancing the comfort and effectiveness of treatment, for individuals suffering from sleep apnea.
August 2024 : Philips Respironics introduced the version of its innovative Optilife mandibular advancement device. This new model includes parts and easy to use adjustments, for maximum comfort and user satisfaction.

Impact of Industry Transitions on the Mandibular Advancement Devices Market

As a core segment of the Medical Device industry, the Mandibular Advancement Devices market develops in line with broader industry shifts. Over recent years, transitions such as Technological Innovations and Regulation and Compliance Standards have redefined priorities across the Medical Device sector, influencing how the Mandibular Advancement Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Innovations

The MAD market experiences a fundamental change because new technologies create better options for individualized treatment and improved patient adherence to treatment. The use of thermoplastic materials together with computer-assisted design by manufacturers has produced devices which provide better fit and comfort to users. The development process has brought better results for sleep apnea treatment while creating more efficient manufacturing methods which decrease expenses and shorten production time. The market shows 6.4% annual growth but industry stakeholders plan to dedicate $30 million through 2030 to drive faster implementation of these new technologies. The sector demonstrates its dedication to advanced technology through this forward-thinking strategy which makes MAD essential for sleep therapy development in the future.
02

Regulation and Compliance Standards

Regulation and compliance standards are playing an increasingly influential role in shaping the MAD market by ensuring product safety, efficacy, and clinical reliability. Regulatory bodies across key regions are enforcing stricter approval processes, quality certifications, and clinical validation requirements for mandibular advancement devices used in sleep apnea and bruxism treatment. Compliance with standards such as ISO certifications and medical device regulations has encouraged manufacturers to improve material quality, design precision, and documentation practices. While these regulations may increase development costs and approval timelines, they also enhance patient trust, support wider insurance coverage, and promote long-term market sustainability by discouraging low-quality or non-compliant products.